AMGN—ODAC/CTGTAC* panels will jointly review T-Vec BLA on 4/29/15: http://finance.yahoo.com/news/amgen-announces-fda-advisory-committees-212200072.html *Cellular, Tissue, and Gene Therapies Advisory Committee.